CD4 and neoplasm: In comparison to Tregs, proinflammatory CD4+ Th17 cells appear to exhibit high aerobic glycolysis, which is a prerequisite for IL‐17 and IL‐22 production, thereby enhancing self‐renewal and tumour cell proliferation, respectively.